|
PRPF38B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.092800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.137000E-01 |
| Normal-vs-Stage2 |
5.839400E-01 |
| Normal-vs-Stage3 |
8.710800E-01 |
| Normal-vs-Stage4 |
9.583200E-01 |
| Stage1-vs-Stage2 |
6.384800E-01 |
| Stage1-vs-Stage3 |
7.291200E-01 |
| Stage1-vs-Stage4 |
8.715600E-01 |
| Stage2-vs-Stage3 |
4.997600E-01 |
| Stage2-vs-Stage4 |
6.576600E-01 |
| Stage3-vs-Stage4 |
9.462000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.567000E-01 |
| Normal-vs-AfricanAmerican |
9.521200E-01 |
| Normal-vs-Asian |
5.173800E-01 |
| Caucasian-vs-AfricanAmerican |
6.114400E-01 |
| Caucasian-vs-Asian |
7.816400E-01 |
| AfricanAmerican-vs-Asian |
6.453800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.189400E-01 |
| Normal-vs-Female |
3.290800E-01 |
| Male-vs-Female |
4.083600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.697400E-01 |
| Normal-vs-Extreme_Weight |
9.044600E-01 |
| Normal-vs-Obese |
4.019200E-01 |
| Normal-vs-Extreme_Obese |
9.442800E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.522200E-01 |
| Normal_Weight-vs-Obese |
2.458800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.171800E-01 |
| Extreme_Weight-vs-Obese |
3.705000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.863800E-01 |
| Obese-vs-Extreme_Obese |
6.316800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.420300E-02 |
| Normal-vs-Age(41-60Yrs) |
1.750980E-01 |
| Normal-vs-Age(61-80Yrs) |
7.404000E-01 |
| Normal-vs-Age(81-100Yrs) |
4.778500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.825990E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.796900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.381000E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.554230E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.162500E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.339770E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.855590E-01 |
| Normal-VS-Type2 PRCC |
5.643800E-03 |
| Normal-VS-KIRP CIMP |
2.963800E-02 |
| Normal-VS-Unclassified PRCC |
4.276000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.18680000271709E-08 |
| Type1 PRCC-VS-KIRP CIMP |
2.986400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.195600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.156010E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.343400E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.595400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.959800E-01 |
| Normal-vs-N1 |
2.740000E-01 |
| Normal-vs-N2 |
8.583400E-01 |
| N0-vs-N1 |
3.935600E-02 |
| N0-vs-N2 |
5.363600E-01 |
| N1-vs-N2 |
7.235400E-01 |
|
|
